Company is CVS Pharmacy the Competitor company is Rite Aid

1.Using fundamental analysis, review the crucial ratios in the following categories:

Liquidity

Asset management

Debt

Interest coverage

Profitability

2 Please be sure to compare your calculations for your company to a competitor or to the industry average.

3.What do you anticipate will be the outcome for the company by the end of the current fiscal year ? Do you forecast improvement or loss ?

Below is CVS :

Consolidated Balance Sheets At December 31, 2019 2018 $ In millions, except per share amounts Assets: Cash and cash equivalents Investments Accounts receivable, net Inventories Other current assets Total current assets Long-term investments Property and equipment, net Operating lease right-of-use assets Goodwill Intangible assets, net Separate accounts assets Other assets Total assets 5,683 $ 2,373 19,617 17,516 5,113 50,302 17,314 12,044 20,860 79,749 33,121 4,459 4,600 222,449 $ 4,059 2,522 17,631 16,450 4,581 45,243 15,732 11,349 78,678 36,524 3,884 5,046 196,456 $ $ 10,492 $ 13,601 6,879 2,991 12,133 1,830 1,596 8,925 11,365 6,147 2,939 10,711 1,937 Liabilities: Accounts payable Pharmacy claims and discounts payable Health care costs payable Policyholders' funds Accrued expenses Other insurance liabilities Current portion of operating lease liabilities Short-term debt Current portion of long-term debt Total current liabilities Long-term operating lease liabilities Long-term debt Deferred income taxes Separate accounts liabilities Other long-term insurance liabilities Other long-term liabilities Total liabilities Commitments and contingencies (Note 16) 720 1,265 44,009 3,781 53,303 18,926 64,699 7,294 4,459 7,436 71,444 7,677 3,884 8,119 2,780 137,913 2,162 158,279 Shareholders' equiry: Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding Common stock, par value $0.01: 3,200 shares authorized; 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus Treasury stock, at cost: 425 shares at both December 31, 2019 and 2018 Retained earnings Accumulated other comprehensive income Total CVS Health shareholders' equity Noncontrolling interests Total shareholders' equity Total liabilities and shareholders' equity 45,972 (28,235) 45,108 1,019 63,864 306 64,170 222,449 $ 45,440 (28,228) 40,911 102 58,225 318 58,543 196,456 $ See accompanying notes to consolidated financial statements. 93 RITE AID CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts) March 2, 2019 March 3, 2018 $ 144,353 $ 447,334 1,788,712 1,869,100 1,871,941 1,799,539 179,132 181,181 117,581 438,137 4,101,719 4,735,291 1,308,514 1,431,246 1,108,136 1,421,120 448,706 590,443 409,084 594,019 215,208 217,208 $ 7,591,367 $ 8,989,327 $ ASSETS Current assets: Cash and cash equivalents Accounts receivable, net Inventories, net.. Prepaid expenses and other current assets Current assets held for sale Total current assets Property, plant and equipment, net Goodwill.. Other intangibles, net. Deferred tax assets Other assets... Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current maturities of long-term debt and lease financing obligations Accounts payable Accrued salaries, wages and other current liabilities Current liabilities held for sale Total current liabilities. Long-term debt, less current maturities Lease financing obligations, less current maturities Other noncurrent liabilities. Total liabilities ... Commitments and contingencies Stockholders' equity: Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 54,016 and 53,366 Additional paid-in capital Accumulated deficit ... Accumulated other comprehensive loss Total stockholders' equity Total liabilities and stockholders' equity 16,111 $ 20,761 1,618,585 1,651,363 808,439 1,231,736 560,205 2,443,135 3,464,065 3,454,585 3,340,099 24,064 30,775 482,893 553,378 6,404,677 7,388,317 54,016 53,366 5,876,977 5,864,664 (4,713,244) (4,282,471) (31,059) (34,549) 1,186,690 1,601,010 $ 7,591,367 $ 8,989,327 Consolidated Balance Sheets At December 31, 2019 2018 $ In millions, except per share amounts Assets: Cash and cash equivalents Investments Accounts receivable, net Inventories Other current assets Total current assets Long-term investments Property and equipment, net Operating lease right-of-use assets Goodwill Intangible assets, net Separate accounts assets Other assets Total assets 5,683 $ 2,373 19,617 17,516 5,113 50,302 17,314 12,044 20,860 79,749 33,121 4,459 4,600 222,449 $ 4,059 2,522 17,631 16,450 4,581 45,243 15,732 11,349 78,678 36,524 3,884 5,046 196,456 $ $ 10,492 $ 13,601 6,879 2,991 12,133 1,830 1,596 8,925 11,365 6,147 2,939 10,711 1,937 Liabilities: Accounts payable Pharmacy claims and discounts payable Health care costs payable Policyholders' funds Accrued expenses Other insurance liabilities Current portion of operating lease liabilities Short-term debt Current portion of long-term debt Total current liabilities Long-term operating lease liabilities Long-term debt Deferred income taxes Separate accounts liabilities Other long-term insurance liabilities Other long-term liabilities Total liabilities Commitments and contingencies (Note 16) 720 1,265 44,009 3,781 53,303 18,926 64,699 7,294 4,459 7,436 71,444 7,677 3,884 8,119 2,780 137,913 2,162 158,279 Shareholders' equiry: Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding Common stock, par value $0.01: 3,200 shares authorized; 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus Treasury stock, at cost: 425 shares at both December 31, 2019 and 2018 Retained earnings Accumulated other comprehensive income Total CVS Health shareholders' equity Noncontrolling interests Total shareholders' equity Total liabilities and shareholders' equity 45,972 (28,235) 45,108 1,019 63,864 306 64,170 222,449 $ 45,440 (28,228) 40,911 102 58,225 318 58,543 196,456 $ See accompanying notes to consolidated financial statements. 93 RITE AID CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts) March 2, 2019 March 3, 2018 $ 144,353 $ 447,334 1,788,712 1,869,100 1,871,941 1,799,539 179,132 181,181 117,581 438,137 4,101,719 4,735,291 1,308,514 1,431,246 1,108,136 1,421,120 448,706 590,443 409,084 594,019 215,208 217,208 $ 7,591,367 $ 8,989,327 $ ASSETS Current assets: Cash and cash equivalents Accounts receivable, net Inventories, net.. Prepaid expenses and other current assets Current assets held for sale Total current assets Property, plant and equipment, net Goodwill.. Other intangibles, net. Deferred tax assets Other assets... Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current maturities of long-term debt and lease financing obligations Accounts payable Accrued salaries, wages and other current liabilities Current liabilities held for sale Total current liabilities. Long-term debt, less current maturities Lease financing obligations, less current maturities Other noncurrent liabilities. Total liabilities ... Commitments and contingencies Stockholders' equity: Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 54,016 and 53,366 Additional paid-in capital Accumulated deficit ... Accumulated other comprehensive loss Total stockholders' equity Total liabilities and stockholders' equity 16,111 $ 20,761 1,618,585 1,651,363 808,439 1,231,736 560,205 2,443,135 3,464,065 3,454,585 3,340,099 24,064 30,775 482,893 553,378 6,404,677 7,388,317 54,016 53,366 5,876,977 5,864,664 (4,713,244) (4,282,471) (31,059) (34,549) 1,186,690 1,601,010 $ 7,591,367 $ 8,989,327